Patent · US Active

Implants and constructs including hollow fibers

US10952961B2 · kind B2 · utility

0Cited by
101References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2019
Grant dateMar 23, 2021
Priority date
Expiry dateDec 12, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M37/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Hollow fiber drug delivery devices are described. Device can contain structural or solid fibers. Fabric can be formed by fibers being interwoven or joined to each other. All or some of the fibers can be resorbable. Fibers can be subdivided, by deformations or closure points, into numerous compartments that separately deliver drug. Deformations can be located at points of fiber intersection or joining. Different drug or drug formulation can be provided in different places. Fibers can be given appropriate surface treatments or coatings to achieve desired properties such as wetting of pores and surfaces. Different release characteristics in different directions can be achieved. The hollow fibers can contain solid particles of drug, and can contain gel. Possible applications include hernia meshes, pouches, sutures, catheters, wound dressings, stents, nerve regrowth guides, refillable/drainable devices, and devices that deliver drug to lymphatic flow.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.